Zakeri K - Search Results

1

Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer.

Raab G, Yu Y, Sherman E, Wong R, Mell LK, Lee NY, Zakeri K. Raab G, et al. Among authors: zakeri k. Clin Transl Radiat Oncol. 2024 Jan 13;45:100725. doi: 10.1016/j.ctro.2024.100725. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38304239 Free PMC article.

2

Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794.

Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell LK. Zakeri K, et al. Contemp Clin Trials. 2013 Jan;34(1):74-9. doi: 10.1016/j.cct.2012.09.008. Epub 2012 Oct 11. Contemp Clin Trials. 2013. PMID: 23063467 Free PMC article.

3

Race and competing mortality in advanced head and neck cancer.

Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Zakeri K, et al. Oral Oncol. 2014 Jan;50(1):40-4. doi: 10.1016/j.oraloncology.2013.09.012. Epub 2013 Oct 14. Oral Oncol. 2014. PMID: 24134948

4

On lumping, splitting, and the nosology of clinical trial populations and end points.

Mell LK, Zakeri K, Rose BS. Mell LK, et al. Among authors: zakeri k. J Clin Oncol. 2014 Apr 1;32(10):1089-90. doi: 10.1200/JCO.2013.54.4429. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550413 Free article. No abstract available.

5

Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell LK. Zhu H, et al. Among authors: zakeri k. J Med Imaging Radiat Oncol. 2015 Jun;59(3):386-93; quiz 394. doi: 10.1111/1754-9485.12297. Epub 2015 Apr 1. J Med Imaging Radiat Oncol. 2015. PMID: 25828068 Free PMC article.

6

Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer.

Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. Zakeri K, et al. Radiother Oncol. 2015 Apr;115(1):114-9. doi: 10.1016/j.radonc.2015.03.018. Epub 2015 Apr 6. Radiother Oncol. 2015. PMID: 25857696 Free article.

7

Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?

Mell LK, Zakeri K. Mell LK, et al. Among authors: zakeri k. Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):732-4. doi: 10.1016/j.ijrobp.2015.04.040. Int J Radiat Oncol Biol Phys. 2015. PMID: 26104928 No abstract available.

8

Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.

Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Carmona R, et al. Among authors: zakeri k. J Clin Oncol. 2016 Apr 10;34(11):1270-7. doi: 10.1200/JCO.2015.65.0739. Epub 2016 Feb 16. J Clin Oncol. 2016. PMID: 26884579 Free PMC article.

9

Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.

Green G, Carmona R, Zakeri K, Lee CH, Borgan S, Marhoon Z, Sharabi A, Mell LK. Green G, et al. Among authors: zakeri k. PLoS One. 2016 Jul 6;11(7):e0156489. doi: 10.1371/journal.pone.0156489. eCollection 2016. PLoS One. 2016. PMID: 27383192 Free PMC article. Review.

10

Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma.

Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA. Mell LK, et al. Among authors: zakeri k. Clin Cancer Res. 2017 Oct 1;23(19):5696-5702. doi: 10.1158/1078-0432.CCR-16-3232. Epub 2017 Jul 5. Clin Cancer Res. 2017. PMID: 28679776 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page